What is the market doing?
What the tape says about VRDN
Viridian Therapeutics, Inc. is +47% over the past year while the S&P 500 is +23%: 24 points ahead of the market.
+47%
1-year return · S&P 500 +23%
- vs 200-day average
- +0.16%
vs 200-day average · close to trend
- RSI (14)
- 63
RSI (14) · neutral
- Below its 52-week high
- −28%
Below its 52-week high
Details›
- Last close2026-08-26
- $24.25
- 1 monthS&P 500 +3.7%
- +26%
- 1 yearS&P 500 +23%
- +47%
- 5 yearsS&P 500 +87%
- +61%
- vs 50-day average$19.51
- +24%
- 52-week high
- $33.78
- 52-week low
- $13.30
- Annualised volatility
- 69%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $20M
| Year | Return |
|---|---|
| 2026 (year to date) | −22% |
| 2025 | +62% |
| 2024 | −12% |
| 2023 | −25% |
| 2022 | +48% |
| 2021 | +20% |
| 2020 | +128% |
| 2019 | −84% |
| 2018 | −71% |
| 2017 | +108% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +34% |
| Feb | 10 | 1 of 10 | −10% |
| Mar | 10 | 3 of 10 | −9.1% |
| Apr | 10 | 6 of 10 | −1.5% |
| May | 10 | 4 of 10 | +2.3% |
| Jun | 10 | 5 of 10 | +1.2% |
| Jul | 11 | 7 of 11 | +6.3% |
| Aug | 11 | 3 of 11 | −3.5% |
| Sep | 10 | 5 of 10 | +1.7% |
| Oct | 10 | 3 of 10 | −1.0% |
| Nov | 10 | 6 of 10 | +17% |
| Dec | 10 | 4 of 10 | −4.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.